Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 32, 2020 - Issue 5
284
Views
5
CrossRef citations to date
0
Altmetric
Articles

DSM-5 substance use disorder symptom clusters and HIV antiretroviral therapy (ART) adherence

, , , , &
Pages 645-650 | Received 21 Dec 2018, Accepted 24 Oct 2019, Published online: 04 Nov 2019

References

  • Altice, F. L., Springer, S., Buitrago, M., Hunt, D. P., & Friedland, G. H. (2003). Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users. Journal of Urban Health, 80(3), 416–427. doi: 10.1093/jurban/jtg053
  • American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.
  • Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A., & Schoenbaum, E. E. (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17(5), 377–381. doi: 10.1007/s11606-002-0044-3
  • Bonn-Miller, M. O., Oser, M. L., Bucossi, M. M., & Trafton, J. A. (2014). Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms. Journal of Behavioral Medicine, 37(1), 1–10. doi: 10.1007/s10865-012-9458-5
  • Campbell, A. N., Des Jarlais, D., Hannah, C., Braunstein, S., Tross, S., Kersanske, L., … Newville, H. (2016). Antiretroviral medication treatment for all HIV-infected individuals: A protocol using innovative multilevel methodologies to evaluate New York City's universal ART policy among problem substance users. BMC Health Services Research, 16(1), 1–13. doi: 10.1186/s12913-016-1554-8
  • Campbell, A. N., Tross, S., Wolff, M. M., Weaver, L., & Des Jarlais, D. C. (2018). “It’s never just about HIV:” HIV primary care providers’ perception pf substance use in the era of “universal” antiretroviral medication treatment. AIDS & Behavior, 22(3), 1006–1017. doi: 10.1007/s10461-017-2007-z
  • Chibanda, D., Benjamin, L., Weiss, H. A., & Abas, M. (2014). Mental, neurological, and substance use disorders in people living with HIV/AIDS in low-and middle-income countries. Journal of Acquired Immune Deficiency Syndromes, 67, S54–S67. doi: 10.1097/QAI.0000000000000258
  • Cofrancesco Jr, J., Scherzer, R., Tien, P. C., Gibert, C. L., Southwell, H., Sidney, S., … Grunfeld, C. (2008). Illicit drug use and HIV treatment outcomes in a US cohort. Aids (london, England), 22(3), 357–365. doi: 10.1097/QAD.0b013e3282f3cc21
  • DHHS (2015). Appendix 9. Alcohol. 2015–2020 dietary guidelines for Americans. 8th edition. Retrieved from https://health.gov/dietaryguidelines/2015/guidelines/appendix-9/
  • DHHS (2016). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Retrieved from http://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf
  • Durvasula, R., & Miller, T. R. (2014). Substance abuse treatment in persons with HIV/AIDS: Challenges in managing triple diagnosis. Behavioral Medicine, 40(2), 43–52. doi: 10.1080/08964289.2013.866540
  • Giordano, T. P., Guzman, D., Clark, R., Charlebois, E. D., & Bangsberg, D. R. (2004). Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clinical Trials, 5(2), 74–79. doi: 10.1310/JFXH-G3X2-EYM6-D6UG
  • Grant, B. F., Saha, T. D., Ruan, W. J., Goldstein, R. B., Chou, S. P., Jung, J., … Huang, B. (2016). Epidemiology of DSM-5 drug use disorder: Results from the National Epidemiologic Survey on alcohol and related Conditions–III. JAMA Psychiatry, 73(1), 39–47. doi: 10.1001/jamapsychiatry.2015.2132
  • Hartzler, B., Dombrowski, J. C., Crane, H. M., Eron, J. J., Geng, E. H., Mathews, W. C., … Napravnik, S. (2017). Prevalence and predictors of substance use disorders among HIV care enrollees in the United States. AIDS and Behavior, 21(4), 1138–1148. doi: 10.1007/s10461-016-1584-6
  • Hendershot, C. S., Stoner, S. A., Pantalone, D. W., & Simoni, J. M. (2009). Alcohol use and antiretroviral adherence: Review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes, 52(2), 180–202. doi: 10.1097/QAI.0b013e3181b18b6e
  • Hinkin, C. H., Barclay, T. R., Castellon, S. A., Levine, A. J., Durvasula, R. S., Marion, S. D., & Longshore, D. (2007). Drug use and medication adherence among HIV-1 infected individuals. AIDS and Behavior, 11(2), 185–194. doi: 10.1007/s10461-006-9152-0
  • Lehavot, K., Huh, D., Walters, K. L., King, K. M., Andrasik, M. P., & Simoni, J. M. (2011). Buffering effects of general and medication-specific social support on the association between substance use and HIV medication adherence. AIDS Patient Care and STDs, 25(3), 181–189. doi: 10.1089/apc.2010.0314
  • Lucas, G. M. (2011). Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals. Life Sciences, 88(21), 948–952. doi: 10.1016/j.lfs.2010.09.025
  • Lucas, G. M., Chaudhry, A., Hsu, J., Woodson, T., Lau, B., Olsen, Y., & Barditch-Crovo, P. (2010). Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial. Annals of Internal Medicine, 152(11), 704–711. doi: 10.7326/0003-4819-152-11-201006010-00003
  • Malta, M., Magnanini, M. M., Strathdee, S. A., & Bastos, F. I. (2010). Adherence to antiretroviral therapy among HIV-infected drug users: A meta-analysis. AIDS and Behavior, 14(4), 731–747. doi: 10.1007/s10461-008-9489-7
  • Mellins, C. A., Havens, J. F., McDonnell, C., Lichtenstein, C., Uldall, K., Chesney, M., … Bell, J. (2009). Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders. AIDS Care, 21(2), 168–177. doi: 10.1080/09540120802001705
  • Metsch, L. R., Bell, C., Pereyra, M., Cardenas, G., Sullivan, T., Rodriguez, A., … Brewer, T. (2009). Hospitalized HIV-infected patients in the era of highly active antiretroviral therapy. American Journal of Public Health, 99(6), 1045–1049. doi: 10.2105/AJPH.2008.139931
  • Montague, B. T., Kahler, C. W., Colby, S. M., McHugh, R. K., Squires, D., Fitzgerald, B., … Mayer, K. H. (2015). Attitudes and training needs of New England HIV care and addiction treatment providers: Opportunities for better integration of HIV and alcohol treatment services. Addictive Disorders & Their Treatment, 14(1), 16–28. doi: 10.1097/ADT.0000000000000040
  • National Institute on Drug Abuse (2016). The science of drug abuse and addiction: The basics. Retrieved from https://www.drugabuse.gov/publications/media-guide/science-drug-abuse-addiction-basics
  • Reback, C., Larkins, S., & Shoptaw, S. (2003). Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care, 15(6), 775–785. doi: 10.1080/09540120310001618621
  • Thompson, M. A., Mugavero, M. J., Amico, K. R., Cargill, V. A., Chang, L. W., Gross, R., & Bartlett, J. G. (2012). Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: Evidence-based recommendations from an International Association of Physicians in AIDS care panel. Annals of Internal Medicine, 156(11), 817–833. doi: 10.7326/0003-4819-156-11-201206050-00419
  • Volkow, N. D., & Montaner, J. (2010). Enhanced HIV testing, treatment, and support for HIV-infected substance users. Journal of Acquired Immune Deficiency Syndromes, 303(14), 1423–1424.
  • WHO (2007). HIV/AIDS treatment and care: clinical protocol for the WHO European Region. WHO Regional Office for Europe. Retrieved from http://www.euro.who.int/__data/assets/pdf_file/0004/78106/E90840.pdf?ua=
  • WHO (2012). Patient evaluation and antiretroviral treatment for adults and adolescents: clinical protocol for the WHO European region. WHO Regional Office for Europe. Retrieved from http://www.euro.who.int/__data/assets/pdf_file/0012/152013/e95794.pdf
  • Yager, J., Faragon, J., McGuey, L., Hoye-Simek, A., Hecox, Z., Sullivan, S., & Patel, N. (2017). Relationship between single tablet antiretroviral regimen and adherence to antiretroviral and non-antiretroviral medications among Veterans’ Affairs patients with human immunodeficiency virus. AIDS Patient Care and STDs, 31(9), 370–376. doi: 10.1089/apc.2017.0081

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.